TruScreen Group Limited (ASX:TRU)
Australia · Delayed Price · Currency is AUD 0.0170
+0.0010 (6.25%)
Feb 11, 2026, 12:49 PM AEST
TruScreen Group Company Description
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa.
It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time.
The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020.
TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
TruScreen Group Limited
| Country | New Zealand |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Martin Dillon |
Contact Details
Address: Equitable House Auckland, 1010 New Zealand | |
| Phone | 61 2 8999 3896 |
| Website | truscreen.com |
Stock Details
| Ticker Symbol | TRU |
| Exchange | Australian Securities Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZTRUE0001S7 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Martin Dillon | Chief Executive Officer |
| Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | Chief Financial Officer and Company Secretary |
| Dr. . Phunc | Head of Cancer Department |
| Dr. . Chuong | Head of Research and Development and Training Department |
| Dr. . Thuy | Head of High Service Gynaecology Examination |